IBDEI0TG ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14541,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,14541,1,5,0)
 ;;=5^Hx of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,14541,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,14542,0)
 ;;=V11.2^^90^861^32
 ;;^UTILITY(U,$J,358.3,14542,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14542,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,14542,1,5,0)
 ;;=5^Hx of Dysthymia
 ;;^UTILITY(U,$J,358.3,14542,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,14543,0)
 ;;=V15.81^^90^861^60
 ;;^UTILITY(U,$J,358.3,14543,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14543,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,14543,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,14543,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,14544,0)
 ;;=V10.43^^90^861^44
 ;;^UTILITY(U,$J,358.3,14544,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14544,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,14544,1,5,0)
 ;;=5^Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,14544,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,14545,0)
 ;;=V12.71^^90^861^45
 ;;^UTILITY(U,$J,358.3,14545,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14545,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,14545,1,5,0)
 ;;=5^Hx of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,14545,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,14546,0)
 ;;=V10.46^^90^861^48
 ;;^UTILITY(U,$J,358.3,14546,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14546,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,14546,1,5,0)
 ;;=5^Hx of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,14546,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,14547,0)
 ;;=V11.0^^90^861^50
 ;;^UTILITY(U,$J,358.3,14547,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14547,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,14547,1,5,0)
 ;;=5^Hx of Schizophrenia
 ;;^UTILITY(U,$J,358.3,14547,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,14548,0)
 ;;=V10.83^^90^861^51
 ;;^UTILITY(U,$J,358.3,14548,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14548,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,14548,1,5,0)
 ;;=5^Hx of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,14548,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,14549,0)
 ;;=V15.1^^90^861^53
 ;;^UTILITY(U,$J,358.3,14549,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14549,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,14549,1,5,0)
 ;;=5^Hx of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,14549,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,14550,0)
 ;;=V15.82^^90^861^57
 ;;^UTILITY(U,$J,358.3,14550,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14550,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,14550,1,5,0)
 ;;=5^Hx of Tobacco Use (not current)
 ;;^UTILITY(U,$J,358.3,14550,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,14551,0)
 ;;=V12.01^^90^861^54
 ;;^UTILITY(U,$J,358.3,14551,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14551,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,14551,1,5,0)
 ;;=5^Hx of TB
 ;;^UTILITY(U,$J,358.3,14551,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,14552,0)
 ;;=V13.01^^90^861^36
 ;;^UTILITY(U,$J,358.3,14552,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14552,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,14552,1,5,0)
 ;;=5^Hx of Kidney Stones
 ;;^UTILITY(U,$J,358.3,14552,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,14553,0)
 ;;=V12.51^^90^861^59
 ;;^UTILITY(U,$J,358.3,14553,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14553,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,14553,1,5,0)
 ;;=5^Hx of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,14553,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,14554,0)
 ;;=V17.89^^90^861^18
 ;;^UTILITY(U,$J,358.3,14554,1,0)
 ;;=^358.31IA^5^2
